I am a biopharmaceutical executive with extensive expertise in bioproduction, business strategy, and innovation management within the biotechnology and healthcare sectors. With over 15 years of experience spanning drug discovery, translational research, and strategic business development, I specialize in forging public-private partnerships, advancing biotherapeutic platforms, and driving commercialization strategies.
Currently, I serve as Chief Business Officer at the Inserm Occitanie Biotherapy-Bioproduction Integrator (OBBI), an initiative under France 2030, where I lead the strategic development, governance, and industrial partnerships to accelerate bioproduction technologies, particularly extracellular vesicles and organoids. My role focuses on commercializing cutting-edge research, establishing key alliances with biotech and pharma companies, and implementing technology transfer strategies to transform innovative therapies into industry-ready solutions.
Beyond my executive role, I act as an expert consultant for global life sciences firms, providing strategic insights on market trends, competitive intelligence, and business planning.
Previously, I was R&D Director at Sensorion, where I managed preclinical drug development programs, including gene therapies and small molecule candidates, contributing to the advancement of neurological disorder treatments.
I also conducted postdoctoral research at Institut Pasteur and Institut Curie, where I investigated neurosensory disorders, cytoskeleton dynamics, and signaling pathways in neurodegenerative diseases and oncology. My research contributed to new discoveries in actin and tubulin regulation, hearing loss mechanisms, and microtubule function in sensory cells, leading to high-impact scientific publications.
Throughout my career, I have successfully led cross-functional scientific teams, secured multi-million-euro funding for biopharma projects, and developed strategic roadmaps for emerging biotechnologies.
My expertise extends across oncology, neuroscience, regenerative medicine, and rare diseases, with a strong focus on bioproduction, innovation ecosystems, and technology-driven business models.
Areas of Expertise- Bioproduction & Translational Research (Organoids, Extracellular Vesicles)
- Strategic Business Development & Public-Private Partnerships (Pharma, Biotech, CDMOs)
- Economic & Competitive Intelligence (Market Trends, Strategic Positioning, R&D Roadmapping)
- Technology Transfer & Commercialization (Licensing, Industry-Driven Research)
- Drug Discovery & Development (Gene Therapy, Neurosciences, Oncology, Rare Diseases)
- Governance & Innovation Strategy (Biotech Consortia, Institutional Collaborations)
With a global industry perspective, I bridge scientific excellence, business strategy, and economic intelligence to advance biopharma innovation and transformative healthcare solutions.
What drives me?
- Making connections that matter—between biotech startups, pharma giants, academic pioneers, and investors.
- Enabling business growth through science—turning complex research into viable commercial strategies.
- Empowering innovation ecosystems—because no great idea thrives in isolation.
Beyond the boardrooms and labs, I’m an enthusiast of multicultural experiences, a lifelong learner, and a believer in the power of collaboration to drive meaningful change.
